The scale of the problem

A 2023 landmark study by Skoglund and colleagues, published in the Journal of Child Psychology and Psychiatry, analysed over 5 million individuals in Swedish population registers and found that girls and women were significantly less likely to receive an ADHD diagnosis than boys and men — even after controlling for symptom severity and number of clinical contacts. A 2024 commentary on this study by Agnew-Blais described the phenomenon as women being "hidden in plain sight" within mental health services.

In practical terms: women with ADHD are reaching mental health services at the same rate as men but leaving without a diagnosis. The problem is not one of access — it is one of recognition.

A comprehensive 2021 review published in BMC Psychiatry by Young and colleagues — representing expert consensus from specialists across Europe — noted that the diagnostic gap persists partly because boys are more prone to being over-diagnosed with ADHD when they don't fully meet criteria, while girls are under-diagnosed even when they do.

Why ADHD research got women wrong

To understand the diagnostic gap, you need to understand the research that created it. The foundational studies on ADHD — from the 1970s through the 1990s — were conducted almost exclusively on clinic-referred boys. The criteria for ADHD that emerged from this research were therefore calibrated to a male presentation.

As Rucklidge (2010) noted in a landmark review published in Psychiatric Clinics of North America, this created a circular problem: the diagnostic thresholds were set based on male presentations, which meant female presentations fell below those thresholds, which meant fewer women were diagnosed, which meant fewer women appeared in studies, which reinforced the thresholds. The male bias was self-perpetuating.

Quinn and Madhoo (2014), writing in The Primary Care Companion for CNS Disorders, described this as a "hidden diagnosis" — one that clinicians were systematically failing to identify in women because they were looking for the wrong signs.

The referral bias problem: Research by Gaub and Carlson (1997) showed that boys with ADHD were three times more likely than girls to be referred for clinical evaluation — not because their symptoms were more severe, but because their behavioural presentation was more disruptive to teachers and parents. Girls' internalised distress was less visible and therefore less likely to trigger a referral.

How ADHD presents differently in women — the research evidence

The most consistent finding across the literature is that women and girls with ADHD are significantly more likely to show the inattentive presentation — characterised by difficulty sustaining attention, disorganisation, forgetfulness, and mental restlessness — rather than the hyperactive-impulsive presentation that dominates clinical descriptions.

A meta-analysis by Gershon (2002) found that girls with ADHD showed significantly less hyperactivity and fewer externalising problems than boys, but similar levels of inattention, academic difficulties, and cognitive impairments. Despite equivalent functional impairment, they were less likely to be referred or diagnosed.

Rucklidge's (2010) review identified several consistent gender differences in ADHD presentation:

The comorbidity problem — and how it obscures ADHD

One of the most significant drivers of late diagnosis in women is the presence of comorbid conditions that are identified first and treated in isolation — without any investigation of whether ADHD is their underlying cause.

Hinshaw and colleagues (2012), in a prospective study published in the Journal of Consulting and Clinical Psychology, followed girls with ADHD into adulthood and found significantly elevated rates of depression, anxiety, self-harm, and suicidal ideation. Critically, many of these outcomes were mediated by unaddressed ADHD — the mental health difficulties were downstream consequences of an undiagnosed condition, not independent primary disorders.

Young et al.'s (2020) expert consensus, published in BMC Medicine, explicitly warned that women with ADHD "frequently present to services with depression, anxiety, and emotional dysregulation rather than with the ADHD symptoms themselves" — leading clinicians to treat the secondary conditions while missing the root cause. The result is often years of antidepressants or anxiolytics that provide partial or no relief, because the underlying ADHD remains untreated.

A 2024 study published in the journal European Psychiatry found that women with undiagnosed ADHD were significantly more likely to have received multiple psychiatric diagnoses — including depression, anxiety, and borderline personality disorder — before receiving an ADHD diagnosis. The researchers described this as diagnostic "laddering" — each new diagnosis layering onto the last, while the underlying condition remained unrecognised.

The role of hormones — an underexplored dimension

An increasingly important body of research is examining the relationship between oestrogen, dopamine, and ADHD symptom severity across the female lifespan. A 2024 review published in PMC (National Library of Medicine) on the "lifelong interplay of hormonal fluctuations with mood, cognition, and disease" in female ADHD found that oestrogen plays a significant modulatory role in dopamine regulation — meaning that hormonal changes across the menstrual cycle, pregnancy, and perimenopause can directly influence ADHD symptom severity.

This has two important clinical implications. First, women may experience significant fluctuation in ADHD symptoms that make diagnosis harder — they may appear to cope well during high-oestrogen phases and be severely impaired during low-oestrogen phases. Second, perimenopause — when oestrogen declines substantially and permanently — is a period of significantly worsened ADHD symptoms that is frequently misattributed to depression or cognitive decline associated with ageing.

The review noted that despite this evidence, the vast majority of ADHD clinicians receive no specific training in female hormonal biology and its interaction with ADHD — a significant gap in clinical knowledge.

Think you might have undiagnosed ADHD?

Our free screening assessment is designed to identify ADHD traits in adults — including the inattentive and emotional presentations most common in women. Results are printable for your GP.

Take the free assessment →

The consequences of late diagnosis — what the data shows

Late diagnosis is not merely an inconvenience. Research consistently shows that it has serious, measurable consequences for women's health, wellbeing, and life outcomes.

A 2024 study published in ScienceDirect specifically examining the impact of late ADHD diagnosis on mental health outcomes in females found that women who received a diagnosis later in life had significantly higher rates of depression, anxiety, and burnout compared to those diagnosed earlier — and that many reported the diagnostic delay itself as a source of significant psychological harm, particularly the years of shame and self-blame that preceded understanding.

Hinshaw et al. (2012) found that girls with ADHD had elevated rates of suicide attempts and self-injury by early adulthood — outcomes that were significantly associated with the severity of untreated ADHD-related impairment.

What needs to change — and what you can do now

Research advocates, including the authors of the 2020 expert consensus statement, have called for several systemic changes: gender-balanced ADHD research, training for clinicians in female ADHD presentations, and updated screening tools calibrated to the full range of ADHD presentations rather than the hyperactive-boy stereotype.

While these changes happen at a systemic level, there are steps women can take individually:

References